Genius Sports Ltd (GENI)
Official siteCOMMUNICATION SERVICES • INTERNET CONTENT & INFORMATION • NYSE
Market Cap: $1.68B
Last updated: Nov 17, 2026 at 4:15 PM ET
Genius Sports Ltd (GENI) Statistics
Genius Sports (GENI) has a market cap of $1.68B and an enterprise value of $2.26B. Its share count is up 9.59% from a year earlier. Revenue grew 47.85% over the last 12 months from the 12 months before.
Total Valuation
Enterprise value is 34.63% above the market cap, as debt exceeds cash.
| Market Cap | $1.68B |
|---|---|
| Enterprise Value | $2.26B |
| Latest price (Nov 17, 2026) | $5.89 |
Key Dates
The next earnings report is expected on Mar 2, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 2, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 5, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 1.9x and 2.4x. Its year-end P/S ranged from 2.1x to 5.2x from 2021 to 2025.
| P/S Ratio | 1.9x |
|---|---|
| Forward P/S | 1.6x |
| P/B Ratio | 2.4x |
| P/OCF Ratio | 68.2x |
Enterprise Valuation
Counting debt and cash, the company is valued at 153.5x EBITDA.
| EV / Sales | 2.5x |
|---|---|
| EV / EBITDA | 153.5x |
Price Statistics
The stock is down 38.96% over 52 weeks and trades 6.95% below its 50-day average.
| Beta (1Y) | 1.80 |
|---|---|
| 52-Week Change | -38.96% |
| 1-Month Change | -10.35% |
| 3-Month Change | -24.20% |
| 6-Month Change | +17.56% |
| 5-Year Change | -65.70% |
| Total Return (1Y) | -38.96% |
| Total Return (3Y CAGR) | +4.85% |
| Total Return (5Y CAGR) | -16.22% |
| Return vs SPY (1Y) | -46.33% |
| Max Drawdown (1Y) | -65.52% |
| Max Drawdown (3Y) | -71.07% |
| Sharpe Ratio (1Y) | -0.56 |
| Correlation with SPY (1Y) | 0.33 |
| 50-Day Average | $6.33 |
| 200-Day Average | $6.05 |
| 52-Week Range | $3.83 to $11.57 |
| RSI (14 Days) | 42.2 |
| Average Volume (20 Days) | 7.15M |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 0.94x current liabilities, and total debt is 1.15x shareholder equity.
| Current Ratio | 0.94x |
|---|---|
| Quick Ratio | 0.94x |
| Debt / Equity | 1.15x |
| Debt / EBITDA | 53.86x |
| Interest Coverage | -1.34x |
Returns and Efficiency
Return on invested capital is -6.45% over the last 12 months, against a 5-year average of -30.15%.
| Return on Equity (ROE) | -24.60% |
|---|---|
| Return on Assets (ROA) | -7.77% |
| Return on Invested Capital (ROIC) | -6.45% |
| Return on Capital Employed (ROCE) | -5.87% |
| ROE (5Y Average) | -31.47% |
| ROA (5Y Average) | -23.92% |
| ROIC (5Y Average) | -30.15% |
| Asset Turnover | 0.56x |
| Inventory Turnover | 1327.51x |
| Receivables Turnover | 3.73x |
| Cash Conversion Cycle | 69 days |
Scores
GENI has an Altman Z-Score of 0.05, in the distress zone below 1.81, and a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 0.05 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 3 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue was $893.82M over the last 12 months.
| Revenue | $893.82M |
|---|---|
| Revenue Growth (YoY) | +47.85% |
| Gross Profit | $267.23M |
| Operating Income | -$69.97M |
| Pretax Income | -$163.41M |
| Net Income | -$168.52M |
| EBITDA | $14.62M |
| EBIT | -$94.98M |
| Reported EPS (TTM) | -$0.34 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 31.57% of the $2.17B in total assets.
| Cash and Equivalents | $206.53M |
|---|---|
| Total Debt | $787.35M |
| Net Debt | $580.82M |
| Net Debt Per Share | $2.06 |
| Working Capital | -$32.99M |
| Shareholder Equity | $684.98M |
| Book Value Per Share | $2.43 |
| Tangible Book Value | -$836.36M |
| Total Assets | $2.17B |
| Total Liabilities | $1.48B |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $56.61M of capital spending, operating cash flow left -$32.01M of free cash flow.
| Operating Cash Flow | $24.61M |
|---|---|
| Capital Expenditures | $56.61M |
| Free Cash Flow | -$32.01M |
| FCF Per Share | -$0.12 |
| Depreciation and Amortization | $109.25M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -7.83%, against a 5-year average of -64.37%.
| Gross Margin | 29.90% |
|---|---|
| Operating Margin | -7.83% |
| Pretax Margin | -18.28% |
| Net Margin | -18.85% |
| EBITDA Margin | 1.64% |
| EBIT Margin | -10.63% |
| FCF Margin | -3.58% |
| Gross Margin (5Y Average) | -3.10% |
| Operating Margin (5Y Average) | -64.37% |
| Net Margin (5Y Average) | -65.91% |
Growth
Revenue grew 25.21% a year over 3 years.
| Revenue Growth (3Y CAGR) | +25.21% |
|---|---|
| Revenue Growth (5Y CAGR) | +34.92% |
| Book Value Per Share Growth (2Y CAGR) | +5.26% |
| Tangible Book Per Share Growth (2Y CAGR) | +34.51% |
Dividends and Yields
GENI does not pay a dividend. Its free cash flow yield is -1.92%.
| FCF Yield | -1.92% |
|---|---|
| Shareholder Yield | 0.00% |
Peer Position
Against 10 similar companies, GENI has the 6th highest P/S.
P/S RatioPeer median 2.2x
ROICPeer median -13.72%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +7.55%
| P/S Ratio | 1.9x vs 2.2x median |
|---|---|
| ROIC | -6.45% vs -13.72% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +47.85% vs +7.55% median |
Analyst Forecast
Consensus estimates put revenue growth at 38.22% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +38.22% |
|---|
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About GENI
What is GENI's market cap?
Genius Sports has a market cap of $1.68B. Its enterprise value, which adds debt and subtracts cash, is $2.26B.
How many shares of GENI are outstanding?
Genius Sports has 282.36M shares outstanding. The count is up 9.59% from a year earlier.
Does GENI pay a dividend?
No. Genius Sports does not pay a dividend.
How much debt does GENI have?
Genius Sports has $787.35M of total debt and $206.53M of cash and equivalents, a net debt position of $580.82M.
GENI pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors